This integrated single-cell analysis revealed that Runx2 is an important TF in the T-cell exhaustion process, a finding that may help improve the effectiveness of HCC therapies and warrants further exploration in the quest for more comprehensive and impactful treatment options. The gene discussed is RUNX2; the disease is hepatocellular carcinoma.